Duragesic ® (transdermal fentanyl) in hospice care

American Journal of Hospice and Palliative Medicine

Volumn 13, Issue 6, 1996, Pages 13-15

  Baumrucker, Steven J ^a  

^a East Tennessee State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; NARCOTIC ANALGESIC AGENT;

AGED; ARTICLE; CASE REPORT; DRUG MONITORING; FEMALE; HOSPICE CARE; HUMAN; INTRADERMAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; NEOPLASM; PAIN; PATHOPHYSIOLOGY; PHARMACOKINETICS;

ADMINISTRATION, CUTANEOUS; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; DRUG MONITORING; FEMALE; FENTANYL; HOSPICE CARE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PAIN; THERAPEUTIC EQUIVALENCY;

EID: 0030292564     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/104990919601300608     Document Type: Article

References (6)

1. DURAGESIC Package Insert. Janssen Pharmaceutica; June 1994.
2. Rosow CE, et al: Histamine release during morphine and fentanyl anesthesia. Anesthesiology. 1982;56:93-96.
3. Slover R: Transdermal Fentanyl: Clinical Trial at the University of Colorado. J Pain Symptom Mgt. 1992;7 (suppl 3): S58-S62.
4. Bruera E, et al: Palliative care in a cancer center: Results in 1984 vs 1987. J Pain Symptom Mgt. 1990;5:1-5.
5. Hanks G, et al: Transdermal fentanyl in cancer pain. J Drug Dev. 1994;6(3):99-97.
6. Eisele DW, et al: Transdermal Fentanyl. Otolaryngol Head Neck Surg. 1994;111:680-683.